DSC6 general management and support. March 1, 2026 to april 30, 2026. N01DA-22-2253. Task order no. 75N95026F00001 (TO27).
Ended Awarded Last action
- Contract number
- 75N95026F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $344,996
Award facts
- Opportunity
-
- 75N95026F00001 Solicitation number
- Contract value 100% obligated
- $344,996.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at approximately $345K to The Emmes Company, LLC for general management and support services under the NIDA Data, Statistics, and Clinical Trial Support Center program. The task order, effective March 1, 2026 through April 30, 2026, was issued without a set-aside designation, reflecting Emmes' competitive standing as a research support contractor. Work will be performed in Potomac, Maryland under a cost-plus-fixed-fee contract structure.
This delivery order is issued under a larger $31.2 million Indefinite Delivery Vehicle (IDV) contract between NIDA and Emmes that provides data management, statistical analysis, and clinical trial support services. The Emmes Company, headquartered in Rockville, Maryland, is an established clinical research organization with extensive experience supporting NIH institutes across multiple therapeutic domains. The company's core competencies—including biostatistical analysis, data coordinating center services, protocol monitoring, and clinical research coordination—align directly with NIDA's mission to support the Clinical Trials Network and advance substance abuse research initiatives.
Quick answers
Who was awarded contract 75N95026F00001?
75N95026F00001 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on March 1, 2026.
How much is contract 75N95026F00001 worth?
The government has obligated $344,996 on 75N95026F00001.
Is contract 75N95026F00001 an order under another contract?
Yes. 75N95026F00001 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95026F00001 competed?
The extent of competition for 75N95026F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award